Concepedia

Rogier Mous

RM

18

Publications

1.2K

Citations

15

H-Index

2003

Active since

Affiliations

University Medical Center Utrecht(Current)

Erasmus MC Cancer Institute

Amsterdam UMC Location Vrije Universiteit Amsterdam

Rigshospitalet

Genmab (United States)

Rogier Mous is an author at University Medical Center Utrecht specializing in medicine, oncology, and immunotherapy.

Top concepts

Publications per year

2003–2024

18

Publications

18

Dose escalation of subcutaneous epcoritamab in patients with relapsed or refractory B-cell non-Hodgkin lymphoma: an open-label, phase 1/2 study

Martin Hutchings, Rogier Mous, Michael Roost Clausen et al. · The Lancet · 2021 · 315 citations · Full text

, , +4

VCAM-1-mediated Rac signaling controls endothelial cell-cell contacts and leukocyte transmigration

Sandra van Wetering, Nadia van den Berk, Jaap D. van Buul et al. · American Journal of Physiology-Cell Physiology · 2003 · 236 citations

The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants

Ana Rio‐Machín, Tom Vulliamy, Nele Hug et al. · Nature Communications · 2020 · 114 citations · Full text

Enhanced formation and survival of CD4<sup>+</sup>CD25<sup>hi</sup>Foxp3<sup>+</sup>T-cells in chronic lymphocytic leukemia

Margot Jak, Margot Jak, Rogier Mous et al. · Leukemia & lymphoma/Leukemia and lymphoma · 2009 · 105 citations

Ibrutinib‐associated invasive fungal diseases in patients with chronic lymphocytic leukaemia and non‐Hodgkin lymphoma: An observational study

Rosa Ruchlemer, Ronen Ben‐Ami, Maskit Bar‐Meir et al. · Mycoses · 2019 · 79 citations · Full text

Rows per page

1–5 of 18